Correa Denise D
Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Hematol Oncol Clin North Am. 2006 Dec;20(6):1363-76. doi: 10.1016/j.hoc.2006.09.012.
As effective treatment interventions have increased survival rates, there has been greater awareness that many brain tumor patients experience cognitive dysfunction despite adequate disease control. Cognitive difficulties often have an impact on quality of life and interfere with the patient's ability to function at premorbid levels; however, the incidence of cognitive dysfunction in brain tumor patients is unknown, because it has not been investigated systematically. Future prospective clinical trials in neuro-oncology should include cognitive outcome measures to increase understanding of the contribution of the tumor and the delayed effects of treatment to cognitive dysfunction.
随着有效的治疗干预措施提高了生存率,人们越来越意识到,许多脑肿瘤患者尽管疾病得到了充分控制,但仍会出现认知功能障碍。认知困难往往会影响生活质量,并干扰患者恢复到病前功能水平的能力;然而,脑肿瘤患者认知功能障碍的发生率尚不清楚,因为尚未进行系统研究。未来神经肿瘤学的前瞻性临床试验应纳入认知结果测量,以加深对肿瘤及治疗延迟效应导致认知功能障碍的理解。